Outcome of transcatheter aortic valve replacement in bicuspid aortic valve stenosis with new-generation devices
- PMID: 33201993
- PMCID: PMC8906794
- DOI: 10.1093/icvts/ivaa231
Outcome of transcatheter aortic valve replacement in bicuspid aortic valve stenosis with new-generation devices
Abstract
Objectives: To compare device success and paravalvular leak rates of 3 new-generation transcatheter aortic valve replacement devices in patients with bicuspid aortic valve stenosis and to test their biomechanical performance in a computer-based simulation model of aortic root with increasing ellipticity.
Methods: This retrospective multicentre study included 56 bicuspid aortic valve patients undergoing transcatheter aortic valve replacement with new-generation devices: Lotus/Lotus Edge (N = 15; 27%), Evolut-R (N = 20; 36%) and ACURATE neo (N = 21; 37%). Three virtual simulation models of aortic root with increasing index of eccentricity (0-0.25-0.5) were implemented. Stress distribution, stent-root contact area and paravalvular orifice area were computed.
Results: Device success was achieved in 43/56 patients (77%) with comparable rates among Lotus (87%), Evolut-R (60%) and ACURATE neo (86%; P = 0.085). Moderate paravalvular leak rate was significantly lower in the Lotus group as compared to Evolut-R group (0% vs 30%; P = 0.027) and comparable to the ACURATE neo group (0% vs 10%; P = 0.33). By index of eccentricity = 0.5, Lotus showed a uniform and symmetric pattern of stress distribution with absent paravalvular orifice area, ACURATE neo showed a mild asymmetry with small paravalvular orifice area (1.1 mm2), whereas a severely asymmetric pattern was evident with Evolut-R, resulting in a large paravalvular orifice area (12.0 mm2).
Conclusions: Transcatheter aortic valve replacement in bicuspid aortic valve patients with new-generation devices showed comparable device success rates. Lotus showed moderate paravalvular leak rate comparable to that of ACURATE neo and significantly lower than Evolut-R. On simulation, Lotus and ACURATE neo showed optimal adaptability to elliptic anatomies as compared to Evolut-R.
Keywords: Bicuspid aortic valve; Computational simulation; New-generation devices; Transcatheter aortic valve replacement.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
Figures





Similar articles
-
Outcomes of three different new generation transcatheter aortic valve prostheses.Catheter Cardiovasc Interv. 2020 Feb 15;95(3):398-407. doi: 10.1002/ccd.28524. Epub 2019 Oct 14. Catheter Cardiovasc Interv. 2020. PMID: 31609073
-
Impact of aortic angle on transcatheter aortic valve implantation outcome with Evolut-R, Portico, and Acurate-NEO.Catheter Cardiovasc Interv. 2021 Jan 1;97(1):E135-E145. doi: 10.1002/ccd.28957. Epub 2020 May 13. Catheter Cardiovasc Interv. 2021. PMID: 32400068
-
Transcatheter Aortic Valve Replacement With Next-Generation Self-Expanding Devices: A Multicenter, Retrospective, Propensity-Matched Comparison of Evolut PRO Versus Acurate neo Transcatheter Heart Valves.JACC Cardiovasc Interv. 2019 Mar 11;12(5):433-443. doi: 10.1016/j.jcin.2018.11.036. JACC Cardiovasc Interv. 2019. PMID: 30846081
-
TAVI with the ACURATE neo transcatheter heart valve in special populations: A systematic review.Hellenic J Cardiol. 2022 Jul-Aug;66:67-71. doi: 10.1016/j.hjc.2022.04.005. Epub 2022 May 1. Hellenic J Cardiol. 2022. PMID: 35508295
-
Effectiveness of the new generation transcatheter aortic valve in the real life studies. Review and meta-analysis.Eur Rev Med Pharmacol Sci. 2019 Sep;23(18):8018-8027. doi: 10.26355/eurrev_201909_19018. Eur Rev Med Pharmacol Sci. 2019. PMID: 31599427 Review.
Cited by
-
Transcatheter Heart Valve Implantation in Bicuspid Patients with Self-Expanding Device.Bioengineering (Basel). 2021 Jul 1;8(7):91. doi: 10.3390/bioengineering8070091. Bioengineering (Basel). 2021. PMID: 34356198 Free PMC article.
-
Procedural and clinical outcomes of transcatheter aortic valve replacement in bicuspid aortic valve patients: a systematic review and meta-analysis.Ann Cardiothorac Surg. 2022 Jul;11(4):351-362. doi: 10.21037/acs-2022-bav-22. Ann Cardiothorac Surg. 2022. PMID: 35958529 Free PMC article.
-
Patient-specific Computer Simulation: An Emerging Technology for Guiding the Transcatheter Treatment of Patients with Bicuspid Aortic Valve.Interv Cardiol. 2021 Aug 19;16:e26. doi: 10.15420/icr.2021.09. eCollection 2021 Apr. Interv Cardiol. 2021. PMID: 34721665 Free PMC article. Review.
-
Safety and Efficacy of Myval Implantation in Patients with Severe Bicuspid Aortic Valve Stenosis-A Multicenter Real-World Experience.J Clin Med. 2022 Jan 15;11(2):443. doi: 10.3390/jcm11020443. J Clin Med. 2022. PMID: 35054137 Free PMC article.
References
-
- Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019;380:1695–705. - PubMed
-
- Yoon SH, Lefèvre T, Ahn JM, Perlman GY, Dvir D, Latib A et al. Transcatheter aortic valve replacement with early- and new-generation devices in bicuspid aortic valve stenosis. J Am Coll Cardiol 2016;68:1195–205. - PubMed
-
- Perlman GY, Blanke P, Webb JG. Transcatheter aortic valve implantation in bicuspid aortic valve stenosis. EuroIntervention 2016;12:Y42–5. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources